Phosphate nephropathy: Difference between revisions
| Line 16: | Line 16: | ||
===Gender=== | ===Gender=== | ||
Several studies report, the majority of cases of acute phosphate nephropathy in the female gender. It could be related to their smaller heights and subsequently less GFR as compared to men. | Several studies report, the majority of cases of acute phosphate nephropathy in the female gender. It could be related to their smaller heights and subsequently less GFR as compared to men. <ref name="pmidPMID: 19675530" /> | ||
===Age=== | ===Age=== | ||
Revision as of 15:04, 10 June 2020
|
Phosphate nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Phosphate nephropathy On the Web |
|
American Roentgen Ray Society Images of Phosphate nephropathy |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayesha Javid, MBBS[2]
Overview
Acute phosphate nephropathy is a form of renal injury that occurs as a result of consumption of bowel purgatives which contain oral sodium phosphate (OSP). It can lead to acute kidney injury followed by chronic renal failure. OSP is a commonly used purgative especially before colonoscopy.
Pathophysiology
Causes
Epidemiology and Demographics
Gender
Several studies report, the majority of cases of acute phosphate nephropathy in the female gender. It could be related to their smaller heights and subsequently less GFR as compared to men. [1]
Age
Several epidemiological studies have identified advanced age as an independent risk factor of acute phosphate nephropathy. However, the exact age at which the patient's predisposition increase has not been identified yet. [1]
Risk Factors
Advanced age
Chronic Kidney disease
Hypertension
Drugs
Diabates mellitus
Female gender
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Phosphate Nephropathy Biopsy | X ray | Ultrasound | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies